$173.08
$19.90 for a single vial
SKU TR15
Tirzepatide 15mg
$194.40
Per sealed kit · 10 vials
Tirzepatide is a dual GIP and GLP-1 receptor agonist studied for its effects on appetite signaling, gastric emptying, insulin sensitivity, and body-composition endpoints in metabolic research models.
Ships as one factory-sealed kit of ten individually capped vials from our weight management collection, cold-chain packed with written order confirmation. Need the other size? Flip the toggle above.
1
- Kit contents
- 10 sealed vials
- Collection
- Weight Management
- Shipping
- Cold-chain, from Boise, ID
- Intended use
- Laboratory research only
About Tirzepatide 15mg
Tirzepatide is a synthetic dual agonist that activates both the GIP and GLP-1 incretin receptors. By engaging two complementary incretin pathways rather than one, it produces a stronger effect on satiety signaling, gastric emptying, and post-prandial insulin response than single-receptor GLP-1 compounds studied alongside it.
In published metabolic research, tirzepatide is among the most-studied compounds for body-composition endpoints, with dose-dependent effects on food intake, fasting glucose, and lipid panels. Its long half-life supports once-weekly dosing schedules, which is why nearly all research designs use a weekly rather than daily interval.
Available as a single vial or a factory-sealed kit of ten individually capped vials. Every order is packed cold with a written order confirmation and batch reference, so each vial can be traced back to its certificate of analysis.
Reported benefits in research
- Marked reduction in appetite and food-seeking behavior through dual incretin signaling
- Improved insulin sensitivity and fasting glucose control in metabolic models
- Slowed gastric emptying, extending the sensation of fullness after meals
- Favorable changes in triglycerides and overall lipid profile
- Once-weekly dosing interval with stable plasma levels between doses
How to use it
- Allow the sealed vial to reach room temperature before opening; do not open a vial that is still cold.
- Wipe the rubber stopper with an alcohol prep pad and let it dry.
- Draw the diluent volume called for in your protocol (bacteriostatic water for nearly all peptides, including GHK-Cu; dilute acetic acid water only for sequences that need a low pH, such as IGF-1 LR3) and inject it slowly against the inner glass wall of the vial.
- Swirl gently until fully clear — never shake, as agitation can fracture the peptide chain.
- Typical research protocols begin at the lowest weekly dose and hold it for a full four weeks before any titration step; the lowest effective dose is maintained thereafter rather than escalated on a fixed schedule.
- Label the vial with the compound, concentration, and reconstitution date, then return it to refrigeration between uses.
What it’s studied for
- Appetite and satiety signaling
- Glucose regulation and insulin sensitivity
- Body-weight and adiposity endpoints
Recommended protocol
Typical research protocols use a low starting dose once weekly, held for four weeks before any titration step, with the lowest effective dose maintained thereafter. Reconstitute with bacteriostatic water and swirl gently — never shake.
Storage & handling
Store lyophilized vials refrigerated (2–8°C) and protected from light. Once reconstituted with bacteriostatic water, keep refrigerated and use within the window cited in your research protocol.
All products are sold for laboratory and research use only. Protocol information is a summary of commonly referenced research designs and is not medical advice, a prescription, or a recommendation for human consumption.
More from Weight Management
$226.80
$26.08 for a single vial
$291.60
$33.53 for a single vial